Care Study Group News Today

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.

The clinical outcome of the disease provoked by the Sars-CoV-2 infection, COVID-19, is largely due to the development of interstitial pneumonia accompanied by an Acute Respiratory Distress Syndrome (ARDS), often requiring ventilatory support therapy in Intensive Care Units (ICUs). Current epidemiologic evidence is demonstrating that the COVID-19 prognosis is significantly influenced by its acute complications. Among these, delirium figures as one of the most frequent and severe, especially in th...

What is Long COVID? Whilst COVID-19 symptoms subside in the majority of patients after a couple of weeks, there is an emerging group of people who suffer long-term effects of the infection. This newly emerging condition has been dubbed long COVID and describes people who experience prolonged symptoms for 4 weeks or longer. Affecting about one-in-five people who test positive for COVID-19, the implications and consequences of the syndrome present a growing global health concern. Fatigue and brea...

Employee Benefits 17th December 2020 8:26 pm 18th December 2020 9:38 am By Colin Hawes, Head of Claims , Generali UK Employee Benefits The Coronavirus pandemic currently sweeping the globe may in fact constitute a second and more long term illness to follow in its wake, according to recent research. Long Covid is a term being increasingly used to describe illness in people who have recovered from Covid-19 but are still reporting lasting effects of the infection; which present similarly t...